SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description

   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back


Speaker
Franck Rahaghi, MD, MHS, FCCP
Director of Advanced Lung Disease Clinic
Director, Pulmonary Hypertension Clinic
Chairman, Dept. of Pulmonary and Critical Care
Cleveland Clinic Florida
Weston, FL.

Moderator
Deborah Paschal, CRNP
Clinical Nurse Practitioner
Philadelphia, PA.

Title
: Navigating the Maze of Interstitial Lung Disease: Improving Outcomes through Early Diagnosis
Activity/Course #:
: NCME360
Cost:
: Free
Release/Start Date:
: Oct 08 2018
Expiration Date:
: Oct 07 2019
Topics:
: Pulmonology
Target Audience:
: Primary Care Physicians, Nurse Practitioners and Physician Assistants
Format:
: Webcast
Estimated Time To Complete CME Activity:
: 1.0 Hour
Credit(s):
: 1.0 AMA PRA Category I Credit(s)
1.0 AANP Contact hour(s) which includes 0.50 pharmacology hour(s)
Hardware/Software Requirements:

Program Summary:

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia of unknown cause, occurring primarily in older adults, limited to the lungs, and associated with the histopathologic and/or radiologic pattern of usual interstitial pneumonia. It is the most common and lethal type of idiopathic interstitial pneumonia and is associated with irreversible destruction of the lung.

Recent studies have shown that IPF is more common than previously believed, and its prevalence is increasing. Early diagnosis and treatment of IPF are important, particularly because novel treatments are available that can improve outcomes. This activity will highlight the importance of early identification of patients with potential IPF, how to develop appropriate diagnostic strategies to exclude potential mimickers, and discuss the available therapeutic options, including the role of the primary care clinician to manage the morbidities associated with IPF.


This webcast was recorded live at the Emerging Challenges in Primary Care 2018 Live Virtual Symposium and is being used with the permission of the presenters.

Learning Objectives

After completing this program participants should be able to:

  1. Recognize the importance of early identification of patients with potential idiopathic pulmonary fibrosis (IPF).
  2. Utilize appropriate strategies to diagnose a patient with IPF while excluding other potential mimickers.
  3. Discuss the available therapeutic options for patients with IPF.
  4. Recognize the role of the primary care clinician in managing the multi-morbidities associated with IPF.

How to obtain the CME Certificate

  1. Register for the course at www.naceonline.com.
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 70% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate.
Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1 contact hour of continuing education which includes 0.50 pharmacology hours.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosures are provided below.

Speaker
Franck Rahaghi, MD, MHS, FCCP serves as a consultant and speaker for Boehringer Ingelheim, and Genentech.

Moderator
Deborah Paschal, CRNP, has no relationships to disclose.

Contributing Faculty
Fernando Martinez, MD, MS is on the Advisory Boards of Astra Zeneca, Boehringer Ingelheim, Chicsi, GlaxoSmithKline, Sunovion, Zambon the Study Steering Committee of Astra Zeneca, Boehringer Ingelheim, Bayer, Biogern, Gilead, GlaxoSmithKline, Nitto, ProMetic, Veracyte and the Data and Safety Monitoring Boards of Boehringer Ingelheim, Biogen, Genentech.

Kevin Flaherty, MD, MS Is a Consultant for Boehringer Ingelheim, Veracyte, Roche/Genentech, FibroGen, Sanofi Genzyme.

David J. Lederer, MD, MS is a Consultant for Veracyte.

Arunabh Talwar, MD, FCCP is a Speaker for Boehringer Ingelheim and on an Advisory Board for Genentech.

Activity Planning Commitee
Gregg Sherman, MD, has no relationships to disclose.

Josh Kilbridge, Medical Writer, has no relationship to disclose.

Harvey C. Parker, Ph.D., has no relationships to disclose.

Michelle Frisch, MPH, has no relationships to disclose.

Sheila Lucas, CWEP, has no relationships to disclose.

Sandy Bihlmeyer, MEd, has no relationship to disclose.

Alan Goodstat, LCSW, has no relationships to disclose.
Commercial Support
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.